Aslan Pharmaceuticals Stock Forecast - Daily Balance Of Power
| ASLNDelisted Stock | USD 0.60 0.03 4.76% |
Aslan Stock Forecast is based on your current time horizon.
Aslan |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| 0.3226 | 0.4844 |
| Check Aslan Pharmaceuticals Volatility | Backtest Aslan Pharmaceuticals | Trend Details |
Aslan Pharmaceuticals Trading Date Momentum
| On May 21 2024 Aslan Pharmaceuticals was traded for 3.84 at the closing time. The top price for the day was 4.16 and the lowest listed price was 3.76 . The trading volume for the day was 22.8 K. The trading history from May 21, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.76% . The overall trading delta against the current closing price is 7.77% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Aslan Pharmaceuticals to competition
View Aslan Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Aslan Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Aslan Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aslan Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Aslan Pharmaceuticals stock market strength indicators, traders can identify Aslan Pharmaceuticals entry and exit signals to maximize returns.
Aslan Pharmaceuticals Risk Indicators
The analysis of Aslan Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Aslan Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aslan stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.79 | |||
| Standard Deviation | 9.4 | |||
| Variance | 88.32 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Aslan Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aslan Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aslan Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Aslan Stock
| 0.79 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.8 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.78 | BKRKY | Bank Rakyat | PairCorr |
| 0.63 | PBCRY | Bank Central Asia | PairCorr |
Moving against Aslan Stock
| 0.86 | DIS | Walt Disney | PairCorr |
| 0.83 | T | ATT Inc Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.82 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.79 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.71 | CSCO | Cisco Systems | PairCorr |
The ability to find closely correlated positions to Aslan Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aslan Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aslan Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aslan Pharmaceuticals to buy it.
The correlation of Aslan Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aslan Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aslan Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aslan Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Aslan Stock
If you are still planning to invest in Aslan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aslan Pharmaceuticals' history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |